StockData
Xencor Inc logo

Xencor Inc (XNCR) stock

XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30194% above fair value
$34.39−0.11 (-0.32%)

Close on Nov 18, 2026Market cap $2.56BP/E –Yield –

Xencor total assets

Total assets on the balance sheet at the end of each period.

Xencor's total assets was $724.96M at Jun 30, 2026. For fiscal 2025 it was $875.50M, down 8.0% from the year before. Over ten years it grew 15.5% a year on average. The highest annual figure on record is $965.14M in fiscal 2023.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$875.50M-8.0%
FY2024Dec 31, 2024$951.95M-1.4%
FY2023Dec 31, 2023$965.14M+14.0%
FY2022Dec 31, 2022$846.27M+1.0%
FY2021Dec 31, 2021$838.21M+19.2%
FY2020Dec 31, 2020$703.24M+4.9%
FY2019Dec 31, 2019$670.25M+16.2%
FY2018Dec 31, 2018$576.73M+47.8%
FY2017Dec 31, 2017$390.20M-9.0%
FY2016Dec 31, 2016$428.56M+107.1%
FY2015Dec 31, 2015$206.91M+205.1%
FY2014Dec 31, 2014$67.82M-22.3%
FY2013Dec 31, 2013$87.32M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$724.96M-17.6%
Q1 FY2026Mar 31, 2026$736.85M-18.6%
Q4 FY2025Dec 31, 2025$875.50M-8.0%
Q3 FY2025Sep 30, 2025$868.81M-13.1%
Q2 FY2025Jun 30, 2025$879.42M+4.6%
Q1 FY2025Mar 31, 2025$904.69M+0.9%
Q4 FY2024Dec 31, 2024$951.95M-1.4%
Q3 FY2024Sep 30, 2024$999.90M+28.5%
Q2 FY2024Jun 30, 2024$840.62M+8.0%
Q1 FY2024Mar 31, 2024$896.85M+11.6%
Q4 FY2023Dec 31, 2023$965.14M+14.0%
Q3 FY2023Sep 30, 2023$778.43M-6.8%
Q2 FY2023Jun 30, 2023$778.12M-8.6%
Q1 FY2023Mar 31, 2023$803.41M-6.4%
Q4 FY2022Dec 31, 2022$846.27M+1.0%
Q3 FY2022Sep 30, 2022$835.27M+19.8%
Q2 FY2022Jun 30, 2022$851.33M+22.4%
Q1 FY2022Mar 31, 2022$857.92M+23.8%
Q4 FY2021Dec 31, 2021$838.21M+19.2%
Q3 FY2021Sep 30, 2021$697.26M+7.9%
Q2 FY2021Jun 30, 2021$695.60M+7.9%
Q1 FY2021Mar 31, 2021$692.74M+3.9%
Q4 FY2020Dec 31, 2020$703.24M+4.9%
Q3 FY2020Sep 30, 2020$646.35M-5.8%
Q2 FY2020Jun 30, 2020$644.72M-5.8%
Q1 FY2020Mar 31, 2020$666.96M-4.3%
Q4 FY2019Dec 31, 2019$670.25M+16.2%
Q3 FY2019Sep 30, 2019$686.24M+17.2%
Q2 FY2019Jun 30, 2019$684.75M+15.8%
Q1 FY2019Mar 31, 2019$697.00M+13.8%
Q4 FY2018Dec 31, 2018$576.73M+47.8%
Q3 FY2018Sep 30, 2018$585.59M+47.0%
Q2 FY2018Jun 30, 2018$591.46M+42.1%
Q1 FY2018Mar 31, 2018$612.27M+46.4%
Q4 FY2017Dec 31, 2017$390.20M-9.0%
Q3 FY2017Sep 30, 2017$398.26M+23.6%
Q2 FY2017Jun 30, 2017$416.16M–
Q1 FY2017Mar 31, 2017$418.30M–
Q4 FY2016Dec 31, 2016$428.56M–
Q3 FY2016Sep 30, 2016$322.13M–

More Xencor figures

See a number that looks wrong?